Cargando…

Clinical Characteristics of Dermatomyositis with Interstitial Lung Disease: A Retrospective Case–Control Study

INTRODUCTION: Interstitial lung disease (ILD) is a common complication of dermatomyositis (DM) and one of the main risk factors for poor prognosis in DM patients. The aim of this study was to reveal the clinical characteristics of DM patients with ILD. METHODS: Clinical data from the Second Affiliat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weng, Chenghua, Ding, Zongnan, Zhou, Yiqun, Yang, Qinyi, Xue, Leixi, Zhang, Lei, Wang, Gang, Liu, Zhichun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140193/ https://www.ncbi.nlm.nih.gov/pubmed/36802052 http://dx.doi.org/10.1007/s40744-023-00540-6

Ejemplares similares

Pathogenesis of anti-melanoma differentiation-associated gene-5 (MDA5) dermatomyositis
por: Weng, Chenghua, et al.
Publicado: (2022)

Utility of the ACR-1997, SLICC-2012 and EULAR/ACR-2019 classification criteria for systemic lupus erythematosus: a single-centre retrospective study
por: Lu, Wentian, et al.
Publicado: (2022)

Comparative efficacy and safety of Janus kinase inhibitors and biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and network meta-analysis
por: Weng, Chenghua, et al.
Publicado: (2021)

Iguratimod alleviates tubulo-interstitial injury in mice with lupus
por: Xue, Leixi, et al.
Publicado: (2022)

Characteristics and risk of interstitial lung disease in dermatomyositis and polymyositis: a retrospective cohort study in Japan
por: Hu, Qingqing, et al.
Publicado: (2023)

Risk factors of interstitial lung diseases in clinically amyopathic dermatomyositis
por: Gan, Yu-Zhou, et al.
Publicado: (2020)

Incidence and impact of interstitial lung disease and malignancy in patients with polymyositis, dermatomyositis, and clinically amyopathic dermatomyositis: a retrospective cohort study
por: Ikeda, Satoshi, et al.
Publicado: (2015)

Resistin Expression Is Associated With Interstitial Lung Disease in Dermatomyositis
por: Ye, Lifang, et al.
Publicado: (2022)

Anti-TWEAK Antibody Alleviates Renal Interstitial Fibrosis by Increasing PGC-1α Expression in Lupus Nephritis
por: Xue, Leixi, et al.
Publicado: (2021)

The Clinical Characteristics of Leukopenia in Patients with Systemic Lupus Erythematosus of Han Ethnicity in China: A Cross-Sectional Study
por: Lu, Wentian, et al.
Publicado: (2021)

Clinical nomogram assisting in discrimination of juvenile dermatomyositis-associated interstitial lung disease
por: Hu, Minfei, et al.
Publicado: (2023)

Clinical and Radiological Features of Interstitial Lung Diseases Associated with Polymyositis and Dermatomyositis
por: Palmucci, Stefano, et al.
Publicado: (2022)

Hypertrophic osteoarthropathy
por: Wang, Gang, et al.
Publicado: (2023)

Clinical characteristics of patients under 40 years old with early-onset hyperuricaemia: a retrospective monocentric study in China
por: Zhang, Yi, et al.
Publicado: (2019)

Research progress on amyopathic dermatomyositis associated with interstitial lung disease
por: Bai, Yu, et al.
Publicado: (2020)

Tozinameran: Dermatomyositis complicated by interstitial lung disease: case report
Publicado: (2022)

A Case of Sarcoidosis with Interstitial Lung Disease Mimicking Clinically Amyopathic Dermatomyositis and Rapidly Progressive Interstitial Lung Disease
por: Sato, Shinji, et al.
Publicado: (2014)

Characteristics and prognostic implications of peripheral blood lymphocyte subsets in patients with anti-MDA5 antibody positive dermatomyositis-interstitial lung disease
por: Ren, Fang-Ping, et al.
Publicado: (2023)

The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease
por: Sugiyama, Yumiko, et al.
Publicado: (2018)

Cytokine profiles of amyopathic dermatomyositis with interstitial lung diseases treated with mycophenolate
por: Hayashi, Masachika, et al.
Publicado: (2017)

Allergic Skin Rash Caused by Iguratimod: A Report of Two Cases
por: Lu, Wentian, et al.
Publicado: (2022)

A Rare Case of Primary Sjogren’s Syndrome Coexisting With Gilbert Syndrome
por: Zhang, Lin, et al.
Publicado: (2023)

The clinical application of tumor markers in the screening of malignancies and interstitial lung disease of dermatomyositis/polymyositis patients: A retrospective study
por: Lim, Chong Hong, et al.
Publicado: (2018)

Seronegative rheumatoid arthritis as the first manifestation of multiple myeloma-associated amyloid arthropathy
por: Wang, Gang, et al.
Publicado: (2023)

Gout in the peri-scapular region manifests as paradoxical low back pain
por: Wang, Gang, et al.
Publicado: (2023)

Limitations to the 6-Minute Walk Test in Dermatomyositis with Interstitial Lung Disease in Comparison with Idiopathic Interstitial Pneumonia
por: Someya, Fujiko, et al.
Publicado: (2013)

Pirfenidone in patients with rapidly progressive interstitial lung disease associated with clinically amyopathic dermatomyositis
por: Li, Ting, et al.
Publicado: (2016)

Rituximab in Antimelanoma Differentiation-Associated Protein-5 Dermatomyositis with Interstitial Lung Disease
por: Scirocco, Chiara, et al.
Publicado: (2020)

Fatal rapidly progressive interstitial lung disease in a patient with amyopathic dermatomyositis
por: Mobeireek, Abdullah, et al.
Publicado: (2021)

Interstitial lung disease in an adult patient with dermatomyositis and anti-NXP2 autoantibody
por: Gossez, Morgane, et al.
Publicado: (2015)

The molecular mechanism underlying dermatomyositis related interstitial lung disease: evidence from bioinformatic analysis and in vivo validation
por: Zeng, Li, et al.
Publicado: (2023)

Roles of biomarkers in anti‐MDA5‐positive dermatomyositis, associated interstitial lung disease, and rapidly progressive interstitial lung disease
por: Li, Xiaomeng, et al.
Publicado: (2022)

Elevated Erythrocyte Sedimentation Rate Is Predictive of Interstitial Lung Disease and Mortality in Dermatomyositis: a Korean Retrospective Cohort Study
por: Go, Dong Jin, et al.
Publicado: (2016)

Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease
por: Enomoto, Yasunori, et al.
Publicado: (2017)

A Clinical Risk Model to Predict Rapidly Progressive Interstitial Lung Disease Incidence in Dermatomyositis
por: Li, Yimin, et al.
Publicado: (2021)

Anti-MDA5 Associated Clinically Amyopathic Dermatomyositis With Rapidly Progressive Interstitial Lung Disease
por: Tavakolian, Kameron, et al.
Publicado: (2022)

Adrenomedullin Expression Is Associated With the Severity and Poor Prognosis of Interstitial Lung Disease in Dermatomyositis Patients
por: Ye, Lifang, et al.
Publicado: (2022)

Risk Factors and Predictive Model for Dermatomyositis Associated with Rapidly Progressive Interstitial Lung Disease
por: Wang, Kai, et al.
Publicado: (2022)

Spontaneous pneumomediastinum and cutaneous ulcers complicated in a patient with dermatomyositis and interstitial lung disease
por: Kwon, Mihye
Publicado: (2021)

Chemokine profiles of interstitial pneumonia in patients with dermatomyositis: a case control study
por: Oda, Katsuhiro, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_afqqh2qat16pvntg0u00ftf066